ARCHIVES

FDA News: FDA Taking Comments on “First Generic” ANDA Process

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997